A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy

PURPOSE: Doxorubicin (DOX) is a very effective anticancer agent. However, in its pure form, its application is limited by significant cardiotoxic side effects. The purpose of this study was to develop a controllably activatable chemotherapy prodrug of DOX created by blocking its free amine group wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibsen, Stuart, Zahavy, Eran, Wrasdilo, Wolf, Berns, Michael, Chan, Michael, Esener, Sadik
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916115/
https://www.ncbi.nlm.nih.gov/pubmed/20596761
http://dx.doi.org/10.1007/s11095-010-0183-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916115/
https://www.ncbi.nlm.nih.gov/pubmed/20596761
http://dx.doi.org/10.1007/s11095-010-0183-x

Ejemplares similares